title: US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions.
authors.forename: Leigh G
authors.initials: LG
authors.lastname: Turner
mesh_terms: D000273:Adipose Tissue / Q000166:cytology*; D004864:Equipment and Supplies; D019983:Guideline Adherence; D006801:Humans; D040541:Marketing; D012926:Social Control, Formal; D033581:Stem Cell Transplantation / Q000331:legislation & jurisprudence; D013234:Stem Cells / Q000166:cytology*; D017154:Stromal Cells / Q000166:cytology; D014182:Transplantation, Autologous; D014481:United States; D014486:United States Food and Drug Administration
keywords: US FDA; adipose-derived mesenchymal stromal cells; marketing claims; patient safety